Skip to main content
Erschienen in: Inflammation 2/2017

19.12.2016 | ORIGINAL ARTICLE

Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function

verfasst von: Thomas Helbing, Gwendoline Wiltgen, Alexandra Hornstein, Elena Z. Brauers, Linus Arnold, Adrian Bauer, Jennifer S. Esser, Philipp Diehl, Sebastian Grundmann, Katrin Fink, Cam Patterson, Christoph Bode, Martin Moser

Erschienen in: Inflammation | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The endothelium serves as a selective barrier and controls the exchange of nutrients, hormones, and leukocytes between blood and tissues. Molecular mechanisms contributing to the pathogenesis of endothelial barrier dysfunction remain incompletely understood. Accumulating evidence implicates bone morphogenetic protein (BMP)-modulator BMPER as a key regulator in endothelial biology. Herein, we analyze the impact of BMPER in the control of endothelial barrier function. To assess the role of BMPER in vascular barrier function in mice, we measured the leakage of Evans blue dye from blood into interstitial lung tissue. BMPER+/− mice exhibited a significantly higher degree of vascular leak compared with wild-type siblings. In accordance with our in vivo observation, siRNA-based BMPER knockdown in human umbilical endothelial cells increased endothelial permeability measured by FITC-dextran passage in transwell assays. Mechanistically, BMPER knockdown reduced the expression of VE-cadherin, a pivotal component of endothelial adherens junctions. Conversely, recombinant human BMPER protein upregulated VE-cadherin protein levels and improved endothelial barrier function in transwell assays. The effects of BMPER knockdown on VE-cadherin expression and endothelial permeability were induced by enhanced BMP activity. Supporting this notion, activation of BMP4-Smad-Id1 signaling reduced VE-cadherin levels and impaired endothelial barrier function in vitro. In vivo, Evans blue dye accumulation was higher in the lungs of BMP4-treated C57BL/6 mice compared to controls indicating that BMP4 increased vascular permeability. High levels of BMPER antagonized BMP4-Smad5-Id1 signaling and prevented BMP4-induced downregulation of VE-cadherin and endothelial leakage, suggesting that BMPER exerts anti-BMP effects and restores endothelial barrier function. Taken together, this data demonstrates that BMPER-modulated BMP pathway activity regulates VE-cadherin expression and vascular barrier function.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mehta, D., and A.B. Malik. 2006. Signaling mechanisms regulating endothelial permeability. Physiological Reviews 86(1): 279–367.CrossRefPubMed Mehta, D., and A.B. Malik. 2006. Signaling mechanisms regulating endothelial permeability. Physiological Reviews 86(1): 279–367.CrossRefPubMed
2.
Zurück zum Zitat Vandenbroucke, E., et al. 2008. Regulation of endothelial junctional permeability. Annals of the New York Academy of Sciences 1123: 134–145.CrossRefPubMed Vandenbroucke, E., et al. 2008. Regulation of endothelial junctional permeability. Annals of the New York Academy of Sciences 1123: 134–145.CrossRefPubMed
3.
Zurück zum Zitat Komarova, Y., and A.B. Malik. 2010. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annual Review of Physiology 72: 463–493.CrossRefPubMed Komarova, Y., and A.B. Malik. 2010. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annual Review of Physiology 72: 463–493.CrossRefPubMed
4.
Zurück zum Zitat Vestweber, D. 2008. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arteriosclerosis, Thrombosis, and Vascular Biology 28(2): 223–232.CrossRefPubMed Vestweber, D. 2008. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arteriosclerosis, Thrombosis, and Vascular Biology 28(2): 223–232.CrossRefPubMed
5.
Zurück zum Zitat Giannotta, M., M. Trani, and E. Dejana. 2013. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Developmental Cell 26(5): 441–454.CrossRefPubMed Giannotta, M., M. Trani, and E. Dejana. 2013. VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Developmental Cell 26(5): 441–454.CrossRefPubMed
6.
Zurück zum Zitat Vestweber, D., et al. 2009. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends in Cell Biology 19(1): 8–15.CrossRefPubMed Vestweber, D., et al. 2009. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends in Cell Biology 19(1): 8–15.CrossRefPubMed
7.
Zurück zum Zitat Dejana, E., and D. Vestweber. 2013. The role of VE-cadherin in vascular morphogenesis and permeability control. Progress in Molecular Biology and Translational Science 116: 119–144.CrossRefPubMed Dejana, E., and D. Vestweber. 2013. The role of VE-cadherin in vascular morphogenesis and permeability control. Progress in Molecular Biology and Translational Science 116: 119–144.CrossRefPubMed
8.
Zurück zum Zitat Garcia deVinuesa, A., et al. 2016. BMP signaling in vascular biology and dysfunction. Cytokine and Growth Factor Reviews 27: 65–79.CrossRef Garcia deVinuesa, A., et al. 2016. BMP signaling in vascular biology and dysfunction. Cytokine and Growth Factor Reviews 27: 65–79.CrossRef
9.
10.
Zurück zum Zitat Dyer, L.A., X. Pi, and C. Patterson. 2014. The role of BMPs in endothelial cell function and dysfunction. Trends in Endocrinology and Metabolism 25(9): 472–480.CrossRefPubMedPubMedCentral Dyer, L.A., X. Pi, and C. Patterson. 2014. The role of BMPs in endothelial cell function and dysfunction. Trends in Endocrinology and Metabolism 25(9): 472–480.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Zhang, J.L., et al. 2008. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Developmental Cell 14(5): 739–750.CrossRefPubMed Zhang, J.L., et al. 2008. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Developmental Cell 14(5): 739–750.CrossRefPubMed
12.
Zurück zum Zitat Zakin, L., et al. 2008. Development of the vertebral morphogenetic field in the mouse: interactions between Crossveinless-2 and Twisted Gastrulation. Developmental Biology 323(1): 6–18.CrossRefPubMedPubMedCentral Zakin, L., et al. 2008. Development of the vertebral morphogenetic field in the mouse: interactions between Crossveinless-2 and Twisted Gastrulation. Developmental Biology 323(1): 6–18.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Moser, M., et al. 2003. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Molecular and Cellular Biology 23(16): 5664–5679.CrossRefPubMedPubMedCentral Moser, M., et al. 2003. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Molecular and Cellular Biology 23(16): 5664–5679.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Moser, M., et al. 2007. BMPER is a conserved regulator of hematopoietic and vascular development in zebrafish. Journal of Molecular and Cellular Cardiology 43(3): 243–253.CrossRefPubMedPubMedCentral Moser, M., et al. 2007. BMPER is a conserved regulator of hematopoietic and vascular development in zebrafish. Journal of Molecular and Cellular Cardiology 43(3): 243–253.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Heinke, J., et al. 2008. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circulation Research 103(8): 804–812.CrossRefPubMed Heinke, J., et al. 2008. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circulation Research 103(8): 804–812.CrossRefPubMed
16.
Zurück zum Zitat Pi, X., et al. 2012. Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32(9): 2214–2222.CrossRefPubMedPubMedCentral Pi, X., et al. 2012. Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32(9): 2214–2222.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Helbing, T., et al. 2011. BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood 118(18): 5040–5049.CrossRefPubMed Helbing, T., et al. 2011. BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood 118(18): 5040–5049.CrossRefPubMed
18.
Zurück zum Zitat Ishida, W., et al. 2000. Smad6 is a Smad1/5-induced smad inhibitor: characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. Journal of Biological Chemistry 275(9): 6075–6079.CrossRefPubMed Ishida, W., et al. 2000. Smad6 is a Smad1/5-induced smad inhibitor: characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. Journal of Biological Chemistry 275(9): 6075–6079.CrossRefPubMed
19.
Zurück zum Zitat Yuan, S.Y., and R.R. Rigor. 2010. Regulation of endothelial barrier function. San Rafael: Morgan & Claypool. Yuan, S.Y., and R.R. Rigor. 2010. Regulation of endothelial barrier function. San Rafael: Morgan & Claypool.
20.
Zurück zum Zitat Kelley, R., et al. 2009. A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling. Journal of Cell Biology 184(4): 597–609.CrossRefPubMedPubMedCentral Kelley, R., et al. 2009. A concentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling. Journal of Cell Biology 184(4): 597–609.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Valdimarsdottir, G., et al. 2002. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106(17): 2263–2270.CrossRefPubMed Valdimarsdottir, G., et al. 2002. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106(17): 2263–2270.CrossRefPubMed
22.
Zurück zum Zitat Miriyala, S., et al. 2006. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113(24): 2818–2825.CrossRefPubMed Miriyala, S., et al. 2006. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113(24): 2818–2825.CrossRefPubMed
23.
Zurück zum Zitat Sorescu, G.P., et al. 2004. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circulation Research 95(8): 773–779.CrossRefPubMed Sorescu, G.P., et al. 2004. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a nox1-based NADPH oxidase. Circulation Research 95(8): 773–779.CrossRefPubMed
24.
Zurück zum Zitat Gavard, J. 2014. Endothelial permeability and VE-cadherin: a wacky comradeship. Cell Adhesion & Migration 8(2): 158–164.CrossRef Gavard, J. 2014. Endothelial permeability and VE-cadherin: a wacky comradeship. Cell Adhesion & Migration 8(2): 158–164.CrossRef
25.
Zurück zum Zitat Deanfield, J.E., J.P. Halcox, and T.J. Rabelink. 2007. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10): 1285–1295.PubMed Deanfield, J.E., J.P. Halcox, and T.J. Rabelink. 2007. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10): 1285–1295.PubMed
26.
Zurück zum Zitat Chang, K., et al. 2007. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation 116(11): 1258–1266.CrossRefPubMed Chang, K., et al. 2007. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis. Circulation 116(11): 1258–1266.CrossRefPubMed
27.
Zurück zum Zitat Pardali, E., and P. Ten Dijke. 2012. TGFbeta signaling and cardiovascular diseases. International Journal of Biological Sciences 8(2): 195–213.CrossRefPubMedPubMedCentral Pardali, E., and P. Ten Dijke. 2012. TGFbeta signaling and cardiovascular diseases. International Journal of Biological Sciences 8(2): 195–213.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Csiszar, A., et al. 2006. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. American Journal of Pathology 168(2): 629–638.CrossRefPubMedPubMedCentral Csiszar, A., et al. 2006. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. American Journal of Pathology 168(2): 629–638.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Csiszar, A., et al. 2008. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. American Journal of Physiology - Heart and Circulatory Physiology 295(2): H569–H577.CrossRefPubMedPubMedCentral Csiszar, A., et al. 2008. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells. American Journal of Physiology - Heart and Circulatory Physiology 295(2): H569–H577.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Csiszar, A., S. Lehoux, and Z. Ungvari. 2009. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxidants and Redox Signaling 11(7): 1683–1697.CrossRefPubMedPubMedCentral Csiszar, A., S. Lehoux, and Z. Ungvari. 2009. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxidants and Redox Signaling 11(7): 1683–1697.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Csiszar, A., et al. 2005. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 111(18): 2364–2372.CrossRefPubMed Csiszar, A., et al. 2005. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappaB activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 111(18): 2364–2372.CrossRefPubMed
32.
Zurück zum Zitat Helbing, T., et al. 2013. Inhibition of BMP activity protects epithelial barrier function in lung injury. Journal of Pathology 231(1): 105–116.CrossRefPubMed Helbing, T., et al. 2013. Inhibition of BMP activity protects epithelial barrier function in lung injury. Journal of Pathology 231(1): 105–116.CrossRefPubMed
33.
Zurück zum Zitat Helbing, T., et al. 2010. BMPER is upregulated by statins and modulates endothelial inflammation by intercellular adhesion molecule-1. Arteriosclerosis, Thrombosis, and Vascular Biology 30(3): 554–560.CrossRefPubMed Helbing, T., et al. 2010. BMPER is upregulated by statins and modulates endothelial inflammation by intercellular adhesion molecule-1. Arteriosclerosis, Thrombosis, and Vascular Biology 30(3): 554–560.CrossRefPubMed
34.
Zurück zum Zitat Hussein, K.A., et al. 2014. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy. Experimental Eye Research 125: 79–88.CrossRefPubMedPubMedCentral Hussein, K.A., et al. 2014. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy. Experimental Eye Research 125: 79–88.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Benn, A., et al. 2016. VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling. Journal of Cell Science 129(1): 206–218.CrossRefPubMedPubMedCentral Benn, A., et al. 2016. VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling. Journal of Cell Science 129(1): 206–218.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Bostrom, K.I., et al. 2011. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circulation Research 108(4): 446–457.CrossRefPubMed Bostrom, K.I., et al. 2011. Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circulation Research 108(4): 446–457.CrossRefPubMed
37.
Zurück zum Zitat Bostrom, K., et al. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. Journal of Clinical Investigation 91(4): 1800–1809.CrossRefPubMedPubMedCentral Bostrom, K., et al. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. Journal of Clinical Investigation 91(4): 1800–1809.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Corriere, M.A., et al. 2008. Endothelial Bmp4 is induced during arterial remodeling: effects on smooth muscle cell migration and proliferation. Journal of Surgical Research 145(1): 142–149.CrossRefPubMed Corriere, M.A., et al. 2008. Endothelial Bmp4 is induced during arterial remodeling: effects on smooth muscle cell migration and proliferation. Journal of Surgical Research 145(1): 142–149.CrossRefPubMed
39.
Zurück zum Zitat Wong, W.T., et al. 2010. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circulation Research 107(8): 984–991.CrossRefPubMed Wong, W.T., et al. 2010. Bone morphogenic protein-4 impairs endothelial function through oxidative stress-dependent cyclooxygenase-2 upregulation: implications on hypertension. Circulation Research 107(8): 984–991.CrossRefPubMed
40.
Zurück zum Zitat Corada, M., et al. 1999. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proceedings of the National Academy of Sciences of the United States of America 96(17): 9815–9820.CrossRefPubMedPubMedCentral Corada, M., et al. 1999. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proceedings of the National Academy of Sciences of the United States of America 96(17): 9815–9820.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Chatterjee, A., et al. 2008. Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. American Journal of Physiology - Lung Cellular and Molecular Physiology 294(4): L755–L763.CrossRefPubMed Chatterjee, A., et al. 2008. Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. American Journal of Physiology - Lung Cellular and Molecular Physiology 294(4): L755–L763.CrossRefPubMed
42.
Zurück zum Zitat Murakami, M., et al. 2008. The FGF system has a key role in regulating vascular integrity. Journal of Clinical Investigation 118(10): 3355–3366.CrossRefPubMedPubMedCentral Murakami, M., et al. 2008. The FGF system has a key role in regulating vascular integrity. Journal of Clinical Investigation 118(10): 3355–3366.CrossRefPubMedPubMedCentral
43.
44.
Zurück zum Zitat Helbing, T., et al. 2010. Kruppel-like factor 15 regulates BMPER in endothelial cells. Cardiovascular Research 85(3): 551–559.CrossRefPubMed Helbing, T., et al. 2010. Kruppel-like factor 15 regulates BMPER in endothelial cells. Cardiovascular Research 85(3): 551–559.CrossRefPubMed
Metadaten
Titel
Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function
verfasst von
Thomas Helbing
Gwendoline Wiltgen
Alexandra Hornstein
Elena Z. Brauers
Linus Arnold
Adrian Bauer
Jennifer S. Esser
Philipp Diehl
Sebastian Grundmann
Katrin Fink
Cam Patterson
Christoph Bode
Martin Moser
Publikationsdatum
19.12.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2017
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0490-4

Weitere Artikel der Ausgabe 2/2017

Inflammation 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.